Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Mizuho

Up 77% in the Past Year, This Analyst Says More Upside Is Still in Store for Applied Materials Stock

Mizuho still sees upside in AMAT stock despite its massive 52-week return.

Barchart

Qualcomm Stock: Analyst Estimates & Ratings

Analysts are maintaining a constructive stance on Qualcomm while monitoring its uneven stock performance.

Barchart

Mizuho Says You Should Buy the Dip in Arm Stock. Why?

Arm’s recent slump may look worrying, but Mizuho says the dip could be a compelling entry point for investors.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Should You Buy the Dip in Qualcomm Stock?

After Qualcomm recorded its seventh straight intraday decline, should you capitalize on its dip?

Barchart

2 Analysts Sour On Super Micro: Can SMCI Recover Amid +40% Fall?

Analysts see Super Micro as in a bit of a pickle. See how the company's trade-off between growth and profitability is shifting sentiment around the stock.

MarketBeat

Qualcomm: Wall Street’s Patience Is Wearing Thin

Qualcomm’s first downgrade of 2026 has investors wondering whether this latest pullback is a warning or a buying opportunity.

MarketBeat

China Just Banned Broadcom’s Cybersecurity Solutions. What Does That Mean for AVGO Stock?

Broadcom shares sink as China bans cybersecurity software from U.S. and Israeli companies. Mizuho still sees AVGO stock as worth owning in 2026.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Broadcom Earns ‘Top Pick’ Status From Wall Street’s Biggest Banks

Analysts at big banks are bullish on Broadcom in 2026. At least three have named the stock a "top pick" for the new year.

MarketBeat

Broadcom CEO Hock Tan Just Sold $24 Million Worth of AVGO Stock. Should You Dump Shares Too?

Multiple insiders, including Hock Tan, sold stock in Broadcom last week.

Barchart

Up 32% in the Past Year, Can Microchip Technologies Stock Keep Zooming Higher?

MCHP is riding AI infrastructure momentum, but its lofty valuation suggests much of the upside may already be priced in.

Barchart

Mizuho Says This 1 Lesser-Known Chip Stock Is a Top Buy for 2026

Wall Street is increasingly turning to optical and networking enablers of AI infrastructure, and Lumentum stands out as a high-conviction pick for 2026.

Barchart

Dear Nvidia Stock Fans, Mark Your Calendars for January 5

Be ready for January 5, as Nvidia’s CES 2026 event could mark a pivotal catalyst.

Barchart

Wall Street’s Not Sure What to Think About Nvidia’s Deal for Groq, But Mizuho Says You Should Keep Buying NVDA Stock

Nvidia stock in focus as the chipmaker announces $20 billion Groq deal. Mizuho analyst explains why the transaction is largely bullish for NVDA shares.

Barchart

AMD Stock Is Up 78% in 2025. What to Expect for Shares in 2026... and Beyond

AMD stock had a blockbuster 2025 but Mizuho sees it climbing further next year. Here’s what could drive AMD shares higher in 2026.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Mizuho Says This 1 Agentic AI Company Is the Top Software Stock to Buy in 2026

Despite a rocky year for Salesforce shares, Mizuho remains bullish on the stock, naming it a top software pick for 2026.

Barchart

This Analyst Says IonQ Stock Can Gain Over 75% from Here. Should You Buy It Now?

Wall Street is warming up to quantum computing, and with Mizuho calling for over 75% upside in IonQ, is the stock a buy now?

Barchart

Nvidia Loves This AI Stock — And So Does Wall Street

Nvidia recently invested $2 billion in Synopsys. Japanese bank Mizuho, along with many other Wall Street banks, is bullish on SNPS.

Barchart

Mizuho Is Pounding the Table on DraftKings Stock Here. Should You Buy DKNG?

DraftKings remains a volatile but high‑conviction Mizuho Top Pick, with management guiding to mid‑20s revenue growth, a sharp swing to positive EPS in 2025, and Street targets implying roughly 27% upside as it expands into prediction markets, new states, and deeper media integrations.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Mastercard To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Barchart

Lumentum Just Got a New Street-High Price Target. Should You Buy the Laser Stock Fueling the AI Boom?

Lumentum rides the AI surge, delivering robust profits and eye-catching analyst upgrades.

Benzinga

Amazon To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Barchart

‘Insatiable’ Demand Is Powering This ‘Picks and Shovels’ AI Stock up 245%. Should You Buy It Here?

With Lumentum’s stellar YTD rally and Needham doubling down, should investors seize the moment, or step carefully from here?

Barchart

Analysts Think This Tech Stock Will Power the Next Wave of Hyperscaler Growth. They Just Gave It a New Street-High Price Target.

Lumentum stock has more than tripled investor returns over the past year and trades at a reasonable valuation relative to its growth estimates.

Benzinga

Tesla To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Barchart

Down 26% in the Past Month, Mizuho Analysts Still Think Oracle Stock Can Soar 93%. Should You Buy ORCL Now?

Oracle has corrected significantly, and some analysts believe now's the right time to buy the dip. Should you do it?

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.